Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
PipCast®
PTE
Trade Marks
Webinars

Bio-Thera Confirms Similarity of BAT2206 to Janssen’s Stelara® (ustekinumab)

Nov 29, 2023

Bio-Thera Solutions announced that its phase III study of BAT2206 demonstrated it is highly similar to Janssen’s Stelara® (ustekinumab) in patients with moderate to severe plaque psoriasis.  Bio-Thera confirmed it will present the results at a future medical meeting or in a publication.

On 16 June 2023, Bio-Thera entered a distribution agreement for BAT2206 in Brazil.  In 2021 Bio-Thera entered into a licence agreement with Hikma for the US (with option to add Europe) and with Pharmapark for Russia and other CIS countries.